The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
NF-κB: tumor promoter or suppressor?
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11991 · Cited by 1,434
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
Control of apoptosis by Rel/NF-κB transcription factors
Barkett, M., & Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203238 · Cited by 1,204
Transcription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194
Aberrant rel/nfkb genes and activity in human cancer
Rayet, B., & Gélinas, C. (1999) · Oncogene · doi:10.1038/sj.onc.1203221 · Cited by 1,110
NF-κB in neuronal plasticity and neurodegenerative disorders
Mattson, M. P., & Camandola, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11916 · Cited by 877
Kieran, M., Blank, V., Logeat, F., Vandekerckhove, J., Lottspeich, F., Le Bail, O., Urban, M. B., Kourilsky, P., Baeuerle, P. A., & Israël, A. (1990) · Cell · doi:10.1016/0092-8674(90)90275-j · Cited by 874
Cloning of the p50 DNA binding subunit of NF-κB: Homology to rel and dorsal
Ghosh, S., Gifford, A. M., Riviere, L. R., Tempst, P., Nolan, G. P., & Baltimore, D. (1990) · Cell · doi:10.1016/0092-8674(90)90276-k · Cited by 852
The Rel/NF-κB Family Directly Activates Expression of the Apoptosis Inhibitor Bcl-x L
Chen, C., Edelstein, L. C., & Gélinas, C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2687-2695.2000 · Cited by 760
Role of NF-κB in p53-mediated programmed cell death
Ryan, K. M., Ernst, M. K., Rice, N. R., & Vousden, K. H. (2000) · Nature · doi:10.1038/35009130 · Cited by 740
NF-κB: pivotal mediator or innocent bystander in atherogenesis?
Collins, T., & Cybulsky, M. I. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10373 · Cited by 727
Hostile takeovers: viral appropriation of the NF-kB pathway
Hiscott, J., Kwon, H., & Génin, P. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11918 · Cited by 613
Transcriptional Cross Talk between NF-κB and p53
Webster, G. A., & Perkins, N. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3485 · Cited by 598
Self-citationNF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., Marinkovich, M. P., Tao, S., Lin, Q., Kubo, Y., et al. (2003) · Nature · doi:10.1038/nature01283 · Cited by 535
Nuclear transcription factor-κB as a target for cancer drug development
Garg, A., & Aggarwal, B. (2002) · Leukemia · doi:10.1038/sj.leu.2402482 · Cited by 441
Seitz, C. S., Lin, Q., Deng, H., & Khavari, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2307 · Cited by 436
The Rel/NF-κB family: friend and foe
Perkins, N. D. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01617-0 · Cited by 375
Self-citationβ-catenin interacts with and inhibits NF-κB in human colon and breast cancer
Deng, J., Miller, S. A., Wang, H.-Y., Xia, W., Wen, Y., Zhou, B. P., Li, Y., Lin, S.-Y., & Hung, M.-C. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00154-x · Cited by 372
Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts
Gerondakis, S., Grossmann, M., Nakamura, Y., Pohl, T., & Grumont, R. (1999) · Oncogene · doi:10.1038/sj.onc.1203236 · Cited by 329
p53 stabilization is decreased upon NFκB activation
Tergaonkar, V., Pando, M., Vafa, O., Wahl, G., & Verma, I. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00068-5 · Cited by 313
van Hogerlinden, M., Rozell, B., Ährlund‐Richter, L., & Toftgård, R. (1999) · PubMed · Cited by 277
Rocha, S., Martin, A. M., Meek, D. W., & Perkins, N. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.13.4713-4727.2003 · Cited by 239
Self-citationMultiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel
Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203222 · Cited by 200
CREB-binding Protein Is a Nuclear Integrator of Nuclear Factor-κB and p53 Signaling
Wadgaonkar, R., Phelps, K. M., Haque, Z., Williams, A. J., Silverman, E. S., & Collins, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.1879 · Cited by 192
p53- and Mdm2-Independent Repression of NF-κB Transactivation by the ARF Tumor Suppressor
Rocha, S., Campbell, K. J., & Perkins, N. D. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00223-5 · Cited by 189
Self-citationAchieving transcriptional specificity with nf-κb
Perkins, N. D. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00088-5 · Cited by 183
Self-citationThe Putative Oncoprotein Bcl-3 Induces Cyclin D1 To Stimulate G1 Transition
Westerheide, S. D., Mayo, M. W., Anest, V., Hanson, J. L., & Baldwin, A. S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8428-8436.2001 · Cited by 182
p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300.
Ravi, R. K., Mookerjee, B., van Hensbergen, Y., Bedi, G. C., Giordano, A., El‐Deiry, W. S., Fuchs, E. J., & Bedi, A. (1998) · PubMed · Cited by 155
Culmsee, C., Siewe, J., Junker, V., Retiounskaia, M., Schwarz, S., Camandola, S., El-Metainy, S., Behnke, H., Mattson, M. P., & Krieglstein, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08586.2003 · Cited by 147
NF-κB: arresting a major culprit in cancer
Haefner, B. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02309-7 · Cited by 138
Gu, L., Findley, H. W., & Zhou, M. (2002) · Blood · doi:10.1182/blood.v99.9.3367 · Cited by 130
Control of development and immunity by Rel transcription factors in Drosophila
Govind, S. (1999) · Oncogene · doi:10.1038/sj.onc.1203223 · Cited by 124
Mayo, M. W., Madrid, L. V., Westerheide, S. D., Jones, D. R., Yuan, X., Baldwin, A. S., & Whang, Y. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108670200 · Cited by 123
Nuclear factor – κB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug
Hellin, A., Calmant, P., GIELEN, J. E., Bours, V., & Merville, M. (1998) · Oncogene · doi:10.1038/sj.onc.1201638 · Cited by 96
INK4 cell cycle inhibitors direct transcriptional inactivation of NF-κB
Wolff, B., & Naumann, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202617 · Cited by 85
Higashitsuji, H., Higashitsuji, H., Nagao, T., Nonoguchi, K., Fujii, S., Itoh, K., & Fujita, J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00152-6 · Cited by 70
relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells
Ricca, A., Biroccio, A., Trisciuoglio, D., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2174 · Cited by 59
Zhou, M., Gu, L., Zhu, N., Woods, W. G., & Findley, H. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206911 · Cited by 54
Chang, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106607200 · Cited by 54
Wilkinson, K. D. (2003) · Nature · doi:10.1038/424738a · Cited by 53
Gapuzan, M.-E. R., Yufit, P. V., & Gilmore, T. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205333 · Cited by 53
Oncogenes, tumor suppressors and p52 NF-κB
Perkins, N. D. (2003) · Oncogene · doi:10.1038/sj.onc.1207139 · Cited by 36
Self-citationWu, B., Woffendin, C., MacLachlan, I., & Nabel, G. J. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.3161-3167.1997 · Cited by 26
Israël, A. (2003) · Nature · doi:10.1038/423596a · Cited by 23
Cited by
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Overview of cell death signaling pathways
Jin, Z., & El-Deiry, W. S. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.2.1508 · Cited by 1,326
The cytoprotective role of the Keap1–Nrf2 pathway
Baird, L., & Dinkova-Kostova, A. T. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0674-5 · Cited by 1,027
TNF-α in promotion and progression of cancer
Balkwill, F. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9005-3 · Cited by 915
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
Luo, J.-L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26322 · Cited by 878
Metadata
- Authors
- Perkins, N. D.
- Venue
- Trends in Cell Biology
- Publisher
- Elsevier BV
- Published
- 2004-02
- Volume
- 14
- Issue
- 2
- Pages
- 64-69
- ISSN
- 0962-8924 (ISSN-L)
- OpenAlex
- W2012612087
- Cited by
- 261
- References
- 51
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.